News
Freshfields Represents Novartis in its Acquisition of DTx Pharma
Freshfields represented Novartis in its acquisition of DTx Pharma, a biotechnology company focused on leveraging its proprietary FALCON platform to develop siRNA therapies for neuroscience indications. The transaction involved an upfront payment of $500 million and additional payments upon completion of pre-specified milestones.
The Freshfields team is led by Adam Golden and Jenny Hochenberg and included Counsel Vinita Sithapathy and Associates Sora Park, Daria Butler and Joshua Samuel on Corporate and Life Sciences matters.
About Freshfields Bruckhaus Deringer LLP
Freshfields Bruckhaus Deringer LLP is a global elite law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on groundbreaking and business-critical mandates. Our 2,800-plus lawyers deliver results worldwide through our own offices and alongside leading local firms. Our commitment, local and multinational expertise, and business know-how means our clients rely on us when it matters most.
Freshfields is ranked by Chambers Global in Band 1 across the six areas of antitrust, corporate/M&A, litigation, international arbitration, tax, and public international law. For more information visit Freshfields.us.
